- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials Sponsored by Salient Pharmaceuticals Incorporated
Total 285 results
-
Salient Pharmaceuticals IncorporatedUnknownDiarrhea | Medullary Thyroid CancerUnited States
-
M.D. Anderson Cancer CenterSalient Pharmaceuticals IncorporatedTerminated
-
Vertex Pharmaceuticals IncorporatedTibotec Pharmaceutical LimitedCompletedHepatitis CAustralia, Canada, France, Italy, Poland, United Kingdom, Germany, United States, Spain, Israel, Argentina, Puerto Rico, Austria
-
Vertex Pharmaceuticals IncorporatedTibotec Pharmaceutical LimitedCompletedHepatitis CUnited States, France, Canada, Germany, Puerto Rico
-
Vertex Pharmaceuticals IncorporatedTibotec Pharmaceutical LimitedCompleted
-
Vertex Pharmaceuticals IncorporatedTibotec Pharmaceutical LimitedCompletedHepatitis CBelgium, United States, Puerto Rico, Netherlands
-
Vertex Pharmaceuticals IncorporatedTibotec Pharmaceutical LimitedCompletedHIV Infections | Hepatitis CFrance, Spain, United States, Germany
-
Vertex Pharmaceuticals IncorporatedNot yet recruiting
-
Vertex Pharmaceuticals IncorporatedRecruitingMyotonic Dystrophy Type 1 (DM1)Canada
-
Vertex Pharmaceuticals IncorporatedRecruitingPainful Lumbosacral RadiculopathyUnited States
-
Vertex Pharmaceuticals IncorporatedRecruiting
-
Vertex Pharmaceuticals IncorporatedRecruitingType 1 DiabetesUnited States, Italy, Canada, Switzerland, Netherlands, Germany, United Kingdom
-
Vertex Pharmaceuticals IncorporatedCompleted
-
Vertex Pharmaceuticals IncorporatedCompleted
-
Vertex Pharmaceuticals IncorporatedActive, not recruitingAlpha-1 Antitrypsin DeficiencyUnited States, United Kingdom, Germany, Ireland
-
Vertex Pharmaceuticals IncorporatedActive, not recruitingCystic FibrosisUnited States, Australia, Germany, Sweden, Switzerland, France, Netherlands, United Kingdom
-
Vertex Pharmaceuticals IncorporatedCompletedAcute PainUnited States
-
Vertex Pharmaceuticals IncorporatedCompletedCystic FibrosisUnited States, United Kingdom, Belgium, Netherlands, France, Denmark, Israel, New Zealand, Australia, Ireland, Sweden, Canada, Germany, Poland, Switzerland, Italy, Austria, Hungary, Greece, Norway
-
Vertex Pharmaceuticals IncorporatedActive, not recruitingCystic FibrosisUnited States, Spain, United Kingdom, Belgium, Netherlands, Denmark, Israel, New Zealand, France, Australia, Ireland, Germany, Sweden, Canada, Czechia, Switzerland, Portugal, Italy, Austria, Hungary, Norway, Poland, Greece
-
Vertex Pharmaceuticals IncorporatedEnrolling by invitationCystic FibrosisUnited States, Australia, Germany, Sweden, Switzerland, France, Netherlands, United Kingdom
-
Vertex Pharmaceuticals IncorporatedActive, not recruitingCystic FibrosisUnited States, Germany, United Kingdom, Canada, Australia, Switzerland, France, Ireland, Belgium, Denmark, Poland
-
Vertex Pharmaceuticals IncorporatedCompletedCystic FibrosisUnited States, Australia, Canada, France, United Kingdom, Germany, Spain, Switzerland, Belgium, Israel, Netherlands, Denmark, Italy, Austria, Ireland, Sweden
-
Vertex Pharmaceuticals IncorporatedCompletedFocal Segmental Glomerulosclerosis (FSGS)United States
-
Vertex Pharmaceuticals IncorporatedCompletedCystic FibrosisUnited States, Canada, United Kingdom, Australia, Ireland
-
Vertex Pharmaceuticals IncorporatedActive, not recruitingCystic FibrosisSpain, Belgium, Netherlands, France, Canada, Germany, Sweden, Switzerland, Italy, Czechia, Portugal, Austria, Hungary, Norway, Poland
-
Vertex Pharmaceuticals IncorporatedCompletedCystic FibrosisFrance, Spain, Belgium, Netherlands, Australia, Italy, Czechia
-
Vertex Pharmaceuticals IncorporatedCompletedCystic FibrosisSpain, Belgium, Netherlands, France, Canada, Germany, Sweden, Italy, Czechia, Switzerland, Portugal, Austria, Hungary, Norway, Poland
-
Vertex Pharmaceuticals IncorporatedCompletedCystic FibrosisBelgium, United Kingdom, Australia, Germany
-
Vertex Pharmaceuticals IncorporatedCompleted
-
Vertex Pharmaceuticals IncorporatedCompleted
-
Vertex Pharmaceuticals IncorporatedCompleted
-
Vertex Pharmaceuticals IncorporatedCompletedCystic FibrosisUnited States, Netherlands, United Kingdom, Germany, Portugal
-
Vertex Pharmaceuticals IncorporatedCompletedAcute PainUnited States
-
Vertex Pharmaceuticals IncorporatedCompletedCystic FibrosisUnited States, Belgium, Netherlands, United Kingdom, Canada, Australia, France, Germany, Italy, Czechia, Austria, Sweden, Greece
-
Vertex Pharmaceuticals IncorporatedCompletedAPOL1-mediated Kidney DiseaseUnited States
-
Vertex Pharmaceuticals IncorporatedCompletedCystic FibrosisNetherlands, United Kingdom
-
Vertex Pharmaceuticals IncorporatedTerminatedAlpha 1-Antitrypsin DeficiencyUnited States, Germany, Canada, Ireland
-
Vertex Pharmaceuticals IncorporatedCompletedCystic FibrosisUnited States, Belgium, Netherlands, Australia, Germany, Ireland, United Kingdom
-
Vertex Pharmaceuticals IncorporatedCompletedSmall Fiber NeuropathyUnited States, Netherlands, Germany, Italy
-
Vertex Pharmaceuticals IncorporatedCompletedCystic FibrosisBelgium, United Kingdom, Australia, Germany
-
Vertex Pharmaceuticals IncorporatedCompleted
-
Vertex Pharmaceuticals IncorporatedApproved for marketing
-
Vertex Pharmaceuticals IncorporatedCompletedCystic FibrosisUnited States, France, United Kingdom, Germany, Belgium, Denmark, Canada, Australia, Sweden
-
Sound Pharmaceuticals, IncorporatedCompleted
-
Vertex Pharmaceuticals IncorporatedCompletedCystic FibrosisUnited States
-
Vertex Pharmaceuticals IncorporatedCompletedOsteoarthritisUnited States
-
Vertex Pharmaceuticals IncorporatedCompletedCystic FibrosisUnited States, Canada, United Kingdom, Australia, Spain, Germany, Italy, Austria, Belgium, Denmark
-
Vertex Pharmaceuticals IncorporatedCompletedCystic FibrosisUnited States, Spain, Ireland, Australia, Israel, United Kingdom, Germany, Switzerland, Canada, Denmark, Poland
-
Vertex Pharmaceuticals IncorporatedCompleted
-
Vertex Pharmaceuticals IncorporatedCompleted